Work

Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Year: 2017

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-017-4377-3

Authors: Steven J. Katz, Sarah T. Hawley, Irina Bondarenko, Reshma Jagsi, Kevin C. Ward, Timothy P. Hofer, Allison W. Kurian

Institutions: University of Michigan, Michigan Medicine, VA Center for Clinical Management Research, Emory University, Stanford Medicine, Stanford University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Centers for Disease Control and Prevention, National Cancer Institute, National Center for Chronic Disease Prevention and Health Promotion

Awards: G1479524499, G1765197379, G2238803135, G3161224617, G3423876156, G480705112, G5333917095, G5570217171, G6011097483, G6102494939, G6656088872

OpenAlex ID: W2730304076

FWCI: 0.409

Cites: 17

Cited by: 8

Related to: 10